Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dermatofibroma. A clinico-pathologic classification scheme]

B G Zelger1, B Zelger

  • 1Institut für Pathologie, Universität Innsbruck, Osterreich.

Der Pathologe
|January 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble PD-L1 shows no association to relapse and overall survival in early stage non-small cell lung cancer (NSCLC).

Lung cancer (Amsterdam, Netherlands)·2024
Same author

Suitability of Fourier transform infrared microscopy for the diagnosis of cystic echinococcosis in human tissue sections.

Journal of biophotonics·2024
Same author

Deep learning analysis of mid-infrared microscopic imaging data for the diagnosis and classification of human lymphomas.

Journal of biophotonics·2023
Same author

Immune cell dynamics deconvoluted by single-cell RNA sequencing in normothermic machine perfusion of the liver.

Nature communications·2023
Same author

Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2022
Same author

Visible and Near-Infrared hyperspectral imaging (HSI) can reliably quantify CD3 and CD45 positive inflammatory cells in myocarditis: Pilot study on formalin-fixed paraffin-embedded specimens from myocard obtained during autopsy.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2022
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Dermatofibromas are common skin lesions with many variants that can mimic other tumors. Understanding these diverse clinicopathologic presentations is key for accurate diagnosis.

Area of Science:

  • Dermatopathology
  • Oncology
  • Histopathology

Context:

  • Dermatofibroma is a frequent benign fibrohistiocytic skin neoplasm.
  • It exhibits significant clinicopathologic heterogeneity.
  • This diversity poses diagnostic challenges, potentially leading to confusion with benign and malignant neoplasms.

Purpose:

  • To categorize and describe the diverse clinicopathologic variants of dermatofibroma.
  • To highlight features that aid in differentiating dermatofibromas from other skin tumors.

Summary:

  • Dermatofibromas are classified into four main groups based on architectural and/or cellular/stromal peculiarities.
  • Variants include those with architectural changes (e.g., deep penetrating, aneurysmal), cellular/stromal changes (e.g., clear cell, atypical), homogenous combinations, and complex composite types.

Related Experiment Videos

  • Specific examples illustrate the wide spectrum, such as epithelioid cell variants and those resembling basal cell carcinoma or neurothekeoma.

    • Impact:

    • Improved diagnostic accuracy for dermatofibromas.
    • Reduced misdiagnosis and unnecessary interventions for benign skin lesions.
    • Enhanced understanding of the spectrum of fibrohistiocytic tumors in dermatopathology.